Varenicline Tablet, Film Coated
Product Images NDC 60687-893

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 60687-893). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ahp89321

Varenicline 1 mg film-coated tablet, oval-shaped and blue in color. One side is embossed with the imprint 'V 2', while the other side is plain. This oral tablet is a prescription drug labeled by American Health Packaging.*

FDA Label Image

1 mg Varenicline Tablets Carton (Image 01)

Varenicline 1 mg film-coated tablets label by American Health Packaging. The label indicates 30 tablets (3 x 10) with a prescription-only designation. It includes storage instructions, active ingredient content, and a QR code for medication guide and prescribing information. Distributed by American Health Packaging in Columbus, Ohio.*

FDA Label Image

1 mg Varenicline Tablet Blister (Image 02)

Label for Varenicline 1 mg film-coated tablets by American Health Packaging. The label includes the product name, strength (1 mg), dosage form (tablet), lot number, and expiration date. It is designed for oral use, with multiple identical labels arranged on the sheet, including barcodes and manufacturer information.*

FDA Label Image

Varenicline-figure3 (Varenicline Figure3)

A line chart titled 'Continuous Abstinence Rate during Nontreatment Follow-Up' comparing Varenicline Tablet 1.0 mg BID and placebo over weeks of nontreatment follow-up. The y-axis represents the percentage of continuous abstinent individuals, and the x-axis shows nontreatment follow-up duration in weeks. Two lines show that abstinence rates decrease over time, with Varenicline maintaining higher rates than placebo throughout the period.*

FDA Label Image

Varenicline-structure (Varenicline Structure)

Chemical structure diagram of varenicline, the active ingredient in Varenicline tartrate tablets. The diagram shows the detailed molecular arrangement of atoms and bonds representing the varenicline compound.*

FDA Label Image

Varenicline_figure1 (Varenicline Fig1)

A bar chart titled "Continuous Abstinence, Weeks 9 through 12" showing the percentage of continuous abstinence across four different studies comparing Varenicline tablets (0.5 mg and 1.0 mg) and other treatments versus placebo. The chart displays the percentage on the vertical axis with categories of treatment on the horizontal axis, including Varenicline 1.0 mg BID, Bupropion SR 150 mg BID, and placebo groups, each with error bars representing variability.*

FDA Label Image

Varenicline-figure2 (Varenicline Figure2)

A bar chart titled 'Continuous Abstinence, Weeks 9 through 52' comparing abstinence rates across five studies involving Varenicline 1.0 mg and 0.5 mg tablets, flexible Varenicline tablets, Bupropion SR 150 mg BID, and placebo. The vertical axis shows percentage abstinence from 0% to 35%, with each study presenting three bars representing different treatments or placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.